Antigens And Vaccines Directed Against Human Enteroviruses


The instant invention provides materials and methods for producing immunologically active antigens derived from members of the Picornaviridae virus family. The picornavirus antigens of the invention may be in a form for use as a vaccine administered to a subject in a therapeutic treatment or for the prevention of a picornavirus infection. The picornavirus antigens of the invention may be in the form of an immunogenic composition for use in vaccines which are administered for the prevention of an Enterovirus infection. The instant invention further encompasses immunogenic compositions comprising Human enterovirus A, Human Enterovirus B, Human enterovirus C, Human Enterovirus D antigens and their use in vaccines for the prevention of an enterovirus infection.

CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jun 5, 2018
  • Application: Nov 1, 2012
    US US 201214402495 A
  • Priority: Nov 1, 2012
    IB IB 2012003114 W
  • Priority: Nov 3, 2011
    MY MY PI2011005318 A

Download Citation

Sign in to the Lens